DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹17,717 Cr | ₹15,937 Cr | ₹14,863 Cr | ₹14,619 Cr | ₹11,387 Cr |
What is the latest Total Liabilities ratio of DIVIS LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹17,717 Cr |
| Mar2024 | ₹15,937 Cr |
| Mar2023 | ₹14,863 Cr |
| Mar2022 | ₹14,619 Cr |
| Mar2021 | ₹11,387 Cr |
How is Total Liabilities of DIVIS LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹17,717 Cr | 11.17 | |
| Mar2024 | ₹15,937 Cr | 7.23 | |
| Mar2023 | ₹14,863 Cr | 1.67 | |
| Mar2022 | ₹14,619 Cr | 28.39 | |
| Mar2021 | ₹11,387 Cr | - | |
Compare Total Liabilities of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹158,175.6 Cr | -0.4% | -7.6% | 5.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,050.0 Cr | -0.9% | -3.9% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,531.0 Cr | -2% | -7.5% | 27.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,190.0 Cr | -1.5% | -9.3% | 3.8% | Stock Analytics | |
| CIPLA | ₹98,892.8 Cr | 1.7% | -8.3% | -16.8% | Stock Analytics | |
| MANKIND PHARMA | ₹84,799.1 Cr | 2.1% | -8.2% | -17% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -0.4% |
-7.6% |
5.4% |
| SENSEX | 4.8% |
-4.2% |
0.8% |
You may also like the below Video Courses